Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
Fermín Sánchez‐Guijo, Mariano García‐Arranz, Miriam López-Parra, et al.
EClinicalMedicine (2020) Vol. 25, pp. 100454-100454
Open Access | Times Cited: 161

Showing 26-50 of 161 citing articles:

Systematic review and meta-analysis of cell therapy for COVID-19: global clinical trial landscape, published safety/efficacy outcomes, cell product manufacturing and clinical delivery
Pedro Silva Couto, Nada Al-Arawe, Igor Salerno Filgueiras, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives.
Shahrzad Najafi, Parizad Najafi, Najmeh Kaffash Farkhad, et al.
PubMed (2023) Vol. 26, Iss. 8, pp. 872-881
Closed Access | Times Cited: 18
Mesenchymal stem cells biological and biotechnological advances: Implications for clinical applications
Jana Pharoun, Jana Berro, Jeanine Sobh, et al.
European Journal of Pharmacology (2024) Vol. 977, pp. 176719-176719
Closed Access | Times Cited: 7
Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential
Ellen Gorman, Jonathan Millar, Daniel F. McAuley, et al.
Expert Review of Respiratory Medicine (2020) Vol. 15, Iss. 3, pp. 301-324
Open Access | Times Cited: 49
Comparison of two ASC-derived therapeutics in an in vitro OA model: secretome versus extracellular vesicles
Chiara Giannasi, Stefania Niada, Cinzia Magagnotti, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 40
Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19
Dhavan Sharma, Feng Zhao
npj Regenerative Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 36
Therapeutic effects of stem cells in different body systems, a novel method that is yet to gain trust: A comprehensive review
Alireza Ebrahimi, Hanie Ahmadi, Zahra Pourfraidon Ghasrodashti, et al.
Bosnian Journal of Basic Medical Sciences (2021)
Open Access | Times Cited: 35
Clinical experience on umbilical cord mesenchymal stem cell treatment in 210 severe and critical COVID-19 cases in Turkey
Nesrin Erçelen, Kubra Cigdem Pekkoc-Uyanik, Nagihan Alpaydin, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 5, pp. 1917-1925
Open Access | Times Cited: 32
Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)
Antonio Pérez‐Martínez, Marta Mora-Rillo, Cristina Ferreras, et al.
EClinicalMedicine (2021) Vol. 39, pp. 101086-101086
Open Access | Times Cited: 32
Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
Weiqi Yao, Lei Shi, Yun Zhang, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Isolation of adipose stromal cells from blood using a two-step microfluidic platform ASCfinder
Mohamed M. Baz, Marion Valette, Mireille André, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Harnessing the Neural Stem Cell Secretome for Regenerative Neuroimmunology
Cory M. Willis, Alexandra M. Nicaise, Regan Hamel, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 33
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation
Isabelle Amigues, Alexander H. Pearlman, Aarat Patel, et al.
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 12, pp. 1185-1204
Open Access | Times Cited: 33
Redressing the interactions between stem cells and immune system in tissue regeneration
Jiankai Fang, Chao Feng, Wangwang Chen, et al.
Biology Direct (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 31
Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities
Susan Moradinasab, Atieh Pourbagheri‐Sigaroodi, Parisa Zafari, et al.
International Immunopharmacology (2021) Vol. 97, pp. 107694-107694
Open Access | Times Cited: 28
Stem cell therapies and benefaction of somatic cell nuclear transfer cloning in COVID-19 era
Birbal Singh, Gorakh Mal, Vinod Verma, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells for COVID-19 pneumonia: a meta-analysis of randomized controlled trials
Qinxue Liu, Fengjie Ma, Yizhi Zhong, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review
Maria Gabriella Matera, Paola Rogliani, Luigino Calzetta, et al.
Respiratory Medicine (2020) Vol. 171, pp. 106114-106114
Open Access | Times Cited: 29
Cell therapy strategies for COVID-19: Current approaches and potential applications
Mark M. Zaki, Emal Lesha, Khaled Saïd, et al.
Science Advances (2021) Vol. 7, Iss. 33
Open Access | Times Cited: 24
Is there a place for mesenchymal stromal cell-based therapies in the therapeutic armamentarium against COVID-19?
Kátia Nunes da Silva, André Luiz Nunes Gobatto, Zaquer Suzana Munhoz Costa-Ferro, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 23
When stem cells meet COVID-19: recent advances, challenges and future perspectives
Shasha Li, Hecheng Zhu, Ming Zhao, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis
Aidan M. Kirkham, Madeline Monaghan, Adrian Bailey, et al.
Cytotherapy (2022) Vol. 24, Iss. 6, pp. 639-649
Open Access | Times Cited: 18
Clinical progress in MSC-based therapies for the management of severe COVID-19
Maria Rossello-Gelabert, Ainhoa Gonzalez‐Pujana, Manoli Igartúa, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 68, pp. 25-36
Open Access | Times Cited: 18
Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
Wenchun Qu, Zhen Wang, Erica Engelberg-Cook, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 7, pp. 688-703
Open Access | Times Cited: 16
Umbilical cord MSC‐derived exosomes improve alveolar macrophage function and reduce LPS‐induced acute lung injury
Enhai Cui, Lu Lv, Bin Wang, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 2
Closed Access | Times Cited: 3

Scroll to top